Sarah Thorning

Sarah Thorning

Auto-generated profile, based on publicly available information

Sarah Thorning

Education and Research Unit, Central Queensland Hospital and Health Service, Rockhampton, Australia

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2011 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
TJTom Jefferson
Tom Jefferson
CMChris B Del Mar
Chris B Del Mar
LDLiz Dooley
Liz Dooley
EFEliana Ferroni
Eliana Ferroni
LALubna A Al-Ansary
Lubna A Al-Ansary
JCJohn M Conly
John M Conly

17 November 2014 in Canadian Medical Association Journal
Verified
Journal Article
Open access
PDF file
MGMalcolm Gillies
Malcolm Gillies
ARAnggi Ranakusuma
Anggi Ranakusuma
THTammy Hoffmann
Tammy Hoffmann
STSarah Thorning
Sarah Thorning
TMTreasure McGuire
Treasure McGuire
CMChristopher Del Mar
Christopher Del Mar
Background: When prescribing antibiotics for common indications, clinicians need information about both harms and benefits, information that is currently available only from observational studies. We quantified the common harms of the most frequently prescribed antibiotic, amoxicillin, from randomized placebo-controlled trials. Methods: For this systematic review, we searched MEDLINE, Embase and the Cochrane Central Register of Controlled Trials, without language restriction, for any randomized, participant-blinded, placebo-controlled trials of amoxicillin or amoxicillin–clavulanic acid for any indication, in any setting. Our main outcome was any reported adverse event. Results: Of 730 studies identified, we included 45 trials: 27 involving amoxicillin, 17 involving amoxicillin–clavulanic acid and 1 involving both. The indications for antibiotic therapy were variable. The risk of bias was low, although only 25 trials provided data suitable for assessment of harms, which suggested under-reporting. Diarrhea was attributed to amoxicillin only in the form of amoxicillin–clavulanic acid (Peto odds ratio [OR] 3.30, 95% confidence interval [CI] 2.23–4.87). The OR for candidiasis (3 trials) was significantly higher (OR 7.77, 95% CI 2.23–27.11). Rashes, nausea, itching, vomiting and abnormal results on liver function tests were not significantly increased. The results were not altered by sensitivity analyses, nor did funnel plots suggest publication bias. The number of courses of antibiotics needed to harm was 10 (95% CI 6–17) for diarrhea with amoxicillin–clavulanic acid and 27 (95% CI 24–42) for candidiasis with amoxicillin (with or without clavulanic acid). Interpretation: Diarrhea was caused by use of amoxicillin–clavulanic acid, and candidiasis was caused by both amoxicillin and amoxicillin–clavulanic acid. Harms were poorly reported in most trials, and their true incidence may have been higher than reported. Nevertheless, these rates of common harms associated with amoxicillin therapy may inform decisions by helping clinicians to balance harms against benefits.

17 May 2012 in BMJ
Verified
Journal Article
Open access
PDF file
THTammy Hoffmann
Tammy Hoffmann
CEChrissy Erueti
Chrissy Erueti
STSarah Thorning
Sarah Thorning
PGPaul Glasziou
Paul Glasziou
Objective To estimate the degree of scatter of reports of randomised trials and systematic reviews, and how the scatter differs among medical specialties and subspecialties. Design Cross sectional analysis. Data source PubMed for all disease relevant randomised trials and systematic reviews published in 2009. Study selection Randomised trials and systematic reviews of the nine diseases or disorders with the highest burden of disease, and the broader category of disease to which each belonged. Results The scatter across journals varied considerably among specialties and subspecialties: otolaryngology had the least scatter (363 trials across 167 journals) and neurology the most (2770 trials across 896 journals). In only three subspecialties (lung cancer, chronic obstructive pulmonary disease, hearing loss) were 10 or fewer journals needed to locate 50% of trials. The scatter was less for systematic reviews: hearing loss had the least scatter (10 reviews across nine journals) and cancer the most (670 reviews across 279 journals). For some specialties and subspecialties the papers were concentrated in specialty journals; whereas for others, few of the top 10 journals were a specialty journal for that area. Generally, little overlap occurred between the top 10 journals publishing trials and those publishing systematic reviews. The number of journals required to find all trials or reviews was highly correlated (r=0.97) with the number of papers for each specialty/subspecialty. Conclusions Publication rates of speciality relevant trials vary widely, from one to seven trials per day, and are scattered across hundreds of general and specialty journals. Although systematic reviews reduce the extent of scatter, they are still widely scattered and mostly in different journals to those of randomised trials. Personal subscriptions to journals, which are insufficient for keeping up to date with knowledge, need to be supplemented by other methods such as journal scanning services or systems that cover sufficient journals and filter articles for quality and relevance. Few current systems seem adequate.

11 September 2016 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
MDMieke L van Driel
Mieke L van Driel
ASAn Im De Sutter
An Im De Sutter
HHHilde Habraken
Hilde Habraken
STSarah Thorning
Sarah Thorning
TCThierry Christiaens
Thierry Christiaens

14 August 2015 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
MHMalene Plejdrup Hansen
Malene Plejdrup Hansen
STSarah Thorning
Sarah Thorning
JAJeffrey K Aronson
Jeffrey K Aronson
EBElaine M Beller
Elaine M Beller
PGPaul P Glasziou
Paul P Glasziou
CMChris B Del Mar
Chris B Del Mar

1 March 2024 in Journal of Voice
Verified
Journal Article
Closed access
HGHeidi Gray
Heidi Gray
LCLeah Coman
Leah Coman
CWChloe Walton
Chloe Walton
STSarah Thorning
Sarah Thorning
ECElizabeth Cardell
Elizabeth Cardell
KWKelly A. Weir
Kelly A. Weir